157 related articles for article (PubMed ID: 31623374)
1. A Nutraceutical Rich in Docosahexaenoic Acid Improves Portal Hypertension in a Preclinical Model of Advanced Chronic Liver Disease.
Boyer-Diaz Z; Domingo JC; De Gregorio E; Manicardi N; Aristu-Zabalza P; Cordobilla B; Abad-Jordà L; Ortega-Ribera M; Fernández-Iglesias A; Marí M; Bosch J; Gracia-Sancho J
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31623374
[TBL] [Abstract][Full Text] [Related]
2. Oxidative Stress in Chronic Liver Disease and Portal Hypertension: Potential of DHA as Nutraceutical.
Boyer-Diaz Z; Morata P; Aristu-Zabalza P; Gibert-Ramos A; Bosch J; Gracia-Sancho J
Nutrients; 2020 Aug; 12(9):. PubMed ID: 32872239
[TBL] [Abstract][Full Text] [Related]
3. Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease.
Boyer-Diaz Z; Aristu-Zabalza P; Andrés-Rozas M; Robert C; Ortega-Ribera M; Fernández-Iglesias A; Broqua P; Junien JL; Wettstein G; Bosch J; Gracia-Sancho J
J Hepatol; 2021 May; 74(5):1188-1199. PubMed ID: 33278455
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria-targeted antioxidant mitoquinone deactivates human and rat hepatic stellate cells and reduces portal hypertension in cirrhotic rats.
Vilaseca M; García-Calderó H; Lafoz E; Ruart M; López-Sanjurjo CI; Murphy MP; Deulofeu R; Bosch J; Hernández-Gea V; Gracia-Sancho J; García-Pagán JC
Liver Int; 2017 Jul; 37(7):1002-1012. PubMed ID: 28371136
[TBL] [Abstract][Full Text] [Related]
5. The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells.
Vilaseca M; García-Calderó H; Lafoz E; García-Irigoyen O; Avila MA; Reverter JC; Bosch J; Hernández-Gea V; Gracia-Sancho J; García-Pagán JC
Hepatology; 2017 Jun; 65(6):2031-2044. PubMed ID: 28142199
[TBL] [Abstract][Full Text] [Related]
6. Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats.
He J; Bai K; Hong B; Zhang F; Zheng S
Int Immunopharmacol; 2017 Dec; 53():56-62. PubMed ID: 29035816
[TBL] [Abstract][Full Text] [Related]
7. The cirrhotic liver is depleted of docosahexaenoic acid (DHA), a key modulator of NF-κB and TGFβ pathways in hepatic stellate cells.
Enguita M; Razquin N; Pamplona R; Quiroga J; Prieto J; Fortes P
Cell Death Dis; 2019 Jan; 10(1):14. PubMed ID: 30622239
[TBL] [Abstract][Full Text] [Related]
8. Enhanced level of n-3 fatty acid in membrane phospholipids induces lipid peroxidation in rats fed dietary docosahexaenoic acid oil.
Song JH; Miyazawa T
Atherosclerosis; 2001 Mar; 155(1):9-18. PubMed ID: 11223421
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats.
Chen WY; Lin SY; Pan HC; Liao SL; Chuang YH; Yen YJ; Lin SY; Chen CJ
J Nutr Biochem; 2012 Mar; 23(3):252-64. PubMed ID: 21497498
[TBL] [Abstract][Full Text] [Related]
10. Omega-3-rich Isochrysis sp. biomass enhances brain docosahexaenoic acid levels and improves serum lipid profile and antioxidant status in Wistar rats.
Balakrishnan J; Dhavamani S; Sadasivam SG; Arumugam M; Vellaikumar S; Ramalingam J; Shanmugam K
J Sci Food Agric; 2019 Oct; 99(13):6066-6075. PubMed ID: 31228262
[TBL] [Abstract][Full Text] [Related]
11. KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins.
Marrone G; Maeso-Díaz R; García-Cardena G; Abraldes JG; García-Pagán JC; Bosch J; Gracia-Sancho J
Gut; 2015 Sep; 64(9):1434-43. PubMed ID: 25500203
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of dietary omega-3 fatty acid supplementation on organophosphate poisoning.
Avci B; Bilge SS; Arslan G; Alici O; Darakci O; Baratzada T; Ciftcioglu E; Yardan T; Bozkurt A
Toxicol Ind Health; 2018 Feb; 34(2):69-82. PubMed ID: 29141517
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension.
Tripathi DM; Vilaseca M; Lafoz E; Garcia-Calderó H; Viegas Haute G; Fernández-Iglesias A; Rodrigues de Oliveira J; García-Pagán JC; Bosch J; Gracia-Sancho J
Gastroenterology; 2018 Nov; 155(5):1564-1577. PubMed ID: 30055171
[TBL] [Abstract][Full Text] [Related]
14. The blockade of lipophagy pathway is necessary for docosahexaenoic acid to regulate lipid droplet turnover in hepatic stellate cells.
Qiu S; Xu H; Lin Z; Liu F; Tan F
Biomed Pharmacother; 2019 Jan; 109():1841-1850. PubMed ID: 30551439
[TBL] [Abstract][Full Text] [Related]
15. Dietary Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA) Operate by Different Mechanisms to Modulate Hepatic Steatosis and Hyperinsulemia in
Hong L; Zahradka P; Cordero-Monroy L; Wright B; Taylor CG
Nutrients; 2019 Apr; 11(4):. PubMed ID: 31022865
[TBL] [Abstract][Full Text] [Related]
16. Healthy effect of different proportions of marine ω-3 PUFAs EPA and DHA supplementation in Wistar rats: Lipidomic biomarkers of oxidative stress and inflammation.
Dasilva G; Pazos M; García-Egido E; Gallardo JM; Rodríguez I; Cela R; Medina I
J Nutr Biochem; 2015 Nov; 26(11):1385-92. PubMed ID: 26320676
[TBL] [Abstract][Full Text] [Related]
17. Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertension.
Jalan R; De Chiara F; Balasubramaniyan V; Andreola F; Khetan V; Malago M; Pinzani M; Mookerjee RP; Rombouts K
J Hepatol; 2016 Apr; 64(4):823-33. PubMed ID: 26654994
[TBL] [Abstract][Full Text] [Related]
18. Docosahexaenoic acid inhibits hepatic stellate cell activation to attenuate liver fibrosis in a PPARγ-dependent manner.
He J; Hong B; Bian M; Jin H; Chen J; Shao J; Zhang F; Zheng S
Int Immunopharmacol; 2019 Oct; 75():105816. PubMed ID: 31437794
[TBL] [Abstract][Full Text] [Related]
19. Role of docosahexaenoic acid treatment in improving liver histology in pediatric nonalcoholic fatty liver disease.
Nobili V; Carpino G; Alisi A; De Vito R; Franchitto A; Alpini G; Onori P; Gaudio E
PLoS One; 2014; 9(2):e88005. PubMed ID: 24505350
[TBL] [Abstract][Full Text] [Related]
20. Liraglutide improves liver microvascular dysfunction in cirrhosis: Evidence from translational studies.
de Mesquita FC; Guixé-Muntet S; Fernández-Iglesias A; Maeso-Díaz R; Vila S; Hide D; Ortega-Ribera M; Rosa JL; García-Pagán JC; Bosch J; de Oliveira JR; Gracia-Sancho J
Sci Rep; 2017 Jun; 7(1):3255. PubMed ID: 28607430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
